Dr. Chris Jenkins, Clinical Biosafety Services Principal Partner & Chief Gene Therapy Biosafety Officer, will be educating us on the updates to the NIH guidelines for research involving human gene therapy.

This event is provided to BioNet members at no additional cost.

Please reply to this email to register.  (DAVIDH@LJI.ORG)